You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information
Home / Tests / Healthcare Associated Infections / Xpert SA Nasal Complete

Xpert® SA Nasal Complete

Pre-surgical testing of S. aureus and MRSA in about an hour

Xpert<sup>®</sup> SA Nasal Complete

The Need


Staphylococcus aureus infections are an increasingly serious public health issue.

Colonized patients at risk for serious complications include surgical, trauma, burn and dialysis patients:

  • S. aureus colonized patients are up to 9 times more likely to develop surgical site infections than non-carriers1
  • S. aureus is the major cause of access infections and bacteremia in dialysis patients2
  • Carriage is the major risk factor for infection with S. aureus in dialysis patients4
  • Up to 93% of nosocomial S. aureus infections are caused by a patient’s own flora3,4
  • SA and MRSA infections are associated with increases in length of hospital stay, costs, morbidity, and mortality6,7,11
  • Nasal carriage of S. aureus and self-infection of wounds in ICU/Burn patients is well documented9,10

The Solution


Rapid and accurate detection of colonization facilitates targeted infection control practices:

  • Optimize pre-admission workflow and counseling
  • Enables measures to reduce endogenous infection risk, including decolonization
  • Supports measures to reduced exogenous infection risk, including barrier/contact precautions
  • Aligns with infection control strategies as outlined by SCIP and SHEA/IDSA

The Impact


Surgical Site Infections (SSIs) due to SA & MRSA significantly increase risk of death, costs and hospitalization as compared to surgeries without SSIs.6,7

 

Rapid detection and implementation of targeted control measures improves your bottom line by reducing adverse medical care events. Hospitals absorb most of the costs for adverse medical care events.

(1) Kluytmans J, et al. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997 Jul;10(3):505-20.
(2) Piraino B. Staphylococcus aureus infections in dialysis patients: focus on prevention. ASAIO J. 2000 Nov-Dec;46(6):S13-7.
(3) Critchley IA. Eradication of MRSA nasal colonization as a strategy for infection prevention. Drug Discov. Today. 2006;3(2):189-95.
(4) Yu VL, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med. 1986 Jul 10;315(2):91-6.
(5) Murphy D, et al. Dispelling the Myths: The True Cost of Healthcare-Associated Infections. An APIC Briefing. 2007 Feb. Accessed May 2020. http://www.thainapci.org/download-guideline-6.pdf/
(6) Engemann JJ, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003 Mar 1;36(5):592-8. Epub 2003 Feb 7.
(7) Anderson, DJ. Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study. PLOS One. 2009 Dec 15. Accessed May 2020. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008305
(8) Bode LG, et al. Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus. N Engl J Med. 2010 Jan 7;362:9-17.
(9) Mackie DP, et al. Reduction in Staphylococcus aureus wound colonization using nasal mupirocin and selective decontamination of the digestive tract in extensive burns. Burns. 1994;20 Suppl 1:S14-7; discussion S17-8.
(10) Kooistra-Smid M, et al. Molecular epidemiology of Staphylococcus aureus colonization in a burn center. Burns. 2004 Feb;30(1):27-33.
(11) Noskin GA, et al. The Burden of Staphylococcus aureus Infections on Hospitals in the United States. Arch Intern Med.2005;165(15):1756–1761.

Ordering Info


Xpert® SA Nasal Complete

Number of Tests: 10

Catalog #: GXSACOMP-10

Educational Materials

Back to Top